All Comments by

  1. Bradley Hyman on Amyloid-beta dynamics correlate with neurological status in the injured human brain.
  2. Johan van Beek on Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
  3. Boris Schmidt on Chicago: Out of the Blue—A Tau-based Treatment for AD?
  4. Terrence Town on Why Good Microglia Turn Bad—A Matter of Timing?
  5. Boris Schmidt on Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
  6. Baoli He on A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis.
  7. Francisco Gonzalez-Lima on Chicago: Out of the Blue—A Tau-based Treatment for AD?
  8. Jane Karlsson on Chicago: Out of the Blue—A Tau-based Treatment for AD?
  9. P.F. Jennings on Chicago: Out of the Blue—A Tau-based Treatment for AD?
  10. Jeffrey Agar on Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.
  11. Paul Coleman on The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.
  12. Wolfgang Streit on Why Good Microglia Turn Bad—A Matter of Timing?
  13. David R. Borchelt on Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.
  14. Steve Barger on A PD Trifecta: Synuclein Gene Expression, Aging, and Inflammation
  15. Milan Fiala on Macrophages Storm Blood-brain Barrier, Clear Plaques—or Do They?